α the properties of alkal-amyloid.
Time of Update: 2020-10-20
According to the enzyme reaction dynamics analysis, for every 10 degrees C increase in temperature, the reaction speed is increased by 1-2 times, so it is resistant to high temperature.
Int Urol Nephrol: Oral probiotics do not change the microbiome of the female urinary system.
Time of Update: 2020-10-11
, the results show that for young healthy women, oral probiotics do not affect the U/L ratio.
Ann Clin Psython: Urinary tract infections in people with schizophrenia may affect cognitive ability.
Time of Update: 2020-10-10
study looked at the prevalence and associated factors of UTI in a large schizophrenia patient queue, and the results were published online by Ann Clin Pycy.
Clin Infect Dis: Fosmycin (ZTI-01) VS The efficacy of pyridoxine-tamabatan in the treatment of complex urinary tract infections.
Time of Update: 2020-10-10
, the results show that ZTI-01 is effective in cUTI treatment, including AP, providing a new intravenous treatment option with differentiated MOA for patients with severe Gloran negative infection.
Urinary incontinence, which is not treated by traditional treatments, see what stem cell technology does.
Time of Update: 2020-10-07
, improve the function of urethra sphides, and promote nerve cell regeneration, injected stem cells can also secrete a variety of factors, promote urethra tissue regeneration, a variety of mechanisms to restore the physiological urinary flow control
FDA awards Disitamab Vedotin (RC48) "breakthrough therapy" for the treatment of urinary endocrine cell carcinoma
Time of Update: 2020-10-05
/> Pharmaceutical Company RemeGen announced today that the U.S. Food and Drug Administration (FDA) has awarded the new humanized anti-HER2 antibody drug co-ed (ADC) Disitamab Vedotin (RC48) the "breakthrough therapy title." Disitamab Vedotin (RC48
Lancet Infect Dis: Bladder phage treats urinary tract infections!
Time of Update: 2020-10-02
bladder phage therapy is no less than standard antibiotic treatment, but for UTI patients treated with TURP, it is no better than placebo bladder flushing.
Risk factors for urinary tract infections associated with catheters in patients admitted to the NICU.
Time of Update: 2020-09-11
and others studied critically ill patients admitted to the NICU to explore the rate and risk factors of urinary tract infections after a patient's presence in a left catheter to provide a basis for the prevention of CAUTI; Research Methods
The three major urinary tumors are most at risk for middle-aged men in the top 10 cancer lists in Beijing.
Time of Update: 2020-08-13
eating grains to reduce prostate cancer high-fiber diets, such as whole grains and plant-based foods, can slow the development of prostate cancer and control the disease early in the prostate cancer.
The new antibiotic Contepo's treatment for complex urinary tract infections was again rejected by the FDA.
Time of Update: 2020-07-29
Nabriva Therapeutics, a biopharmaceutical company dedicated to the development of innovative anti-infective drugs for serious infections, announced that it has received a full response from the FDA (CRL) to reject the application for a new drug (NDA
Several immunotherapy failures of the urinary road skin cancer ushered in a new pattern of first-line maintenance treatment.
Time of Update: 2020-07-24
The JAVELIN Bladder 100 study is a first-line multicenter, randomized Phase III clinical trial designed to assess the efficacy and safety of Avelumab Combined SupportIve Therapy (BSC) in first-line maintenance therapy in locally advanced or metastatic UC patients.
Nat E. Wu Jianxuan and others revealed the immunological causes of the high recurrence rate of urinary tract infections.
Time of Update: 2020-07-21
Responsible . . . Urinary tract infections are collectively referred to as infections caused by various bacteria invading urinary organs such as the urethra, bladder and kidneys. . Urinary tract infections are one of the most common
Neurogenic forced urinary muscle overactivity of new drugs! AbbVie Botox Botox (Paso) US Entry Review: Treatment of Children 5-17 Years!
Time of Update: 2020-07-19
, June 24, 2020 /PRNewswire / -- AbbVie has announced that the U.S. Food and Drug Administration ( FDA ) has accepted a request for a supplemental biologics license (sBLA) to seek to expand Botox.-- A, Botox
inhibitors approved for first-line maintenance treatment for urinary skin cancer.
Time of Update: 2020-07-18
Yesterday, Merck KGaA and Pfizer jointly announced that the U.S. FDA has approved a supplemental biologics license (sBLA) for PD-L1 antibody Bavencio (avelumab) for first-line maintenance treatment for patients with local advanced or metastatic
PD-L1 monoanti-Bavencio: under review in Europe to treat metastatic urinary skin cancer
Time of Update: 2020-07-14
The European Drug Administration is reviewing Merck and Pfizer's PD-L1 monoanti-Bavencio (avelumab) for first-line maintenance treatment for patients with locally advanced or metastatic urinary skin cancer (UC).
FDA rejects Contepo application for complex urinary tract infection
Time of Update: 2020-07-12
Nabriva Therapeutics recently announced that the FDA has again rejected Contepo's application for treatment of complex urinary tract infections (including acute phytomyelitis, cUTI) due to unresolved manufacturing problems.
Mersadon K drug and chemotherapy treatment late or metastatic urinary tract skin cancer phase III clinical failure
Time of Update: 2020-06-26
Guide: Keytruda as Mercadon's "Home flower", although the results of this trial are disappointing, but the drug now has three FDA-approved bladder cancer indications. compilation of Fan Dongdong on June 9est EST, Mercado announced
Keytruda-chemotherapy first-line treatment of advanced or metastatic urinary tract skin cancer phase III clinical failure
Time of Update: 2020-06-26
On June 9EST, Mershadon announced the results of a Phase III clinical trial called KEYNOTE-361. The study, which assessed the efficacy of Keytruda's combination chemotherapy for advanced or metastatic urinary skin cancer (UC), showed that Keytruda
Urinary protein VS urine trace albumin, diabetic sitadown?
Time of Update: 2020-06-25
be actively treated. 1, treatment of primary disease diabetes should control blood sugar, the preferred column of the sugar-lowering drug Cargrenet, Dagre net and engrenet, this type of drug in the sugar-lowering at the same time
J Urol: Why does preventing recurrent urinary tract infections not lead to fewer kidney scars?
Time of Update: 2020-06-24
Antibiotic prevention is associated with a reduced risk of this result when a recurrent urinary tract infection is limited to a new kidney scar.